human non small cell lung cancer cell lines (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
human non small cell lung cancer cell lines
Human Non Small Cell Lung Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2028 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+non+small+cell+lung+cancer+cell+lines/HCC827/pm42134241-86-0-21
Average 99 stars, based on 2028 article reviews
Human Non Small Cell Lung Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2028 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+non+small+cell+lung+cancer+cell+lines/HCC827/pm42134241-86-0-21
Average 99 stars, based on 2028 article reviews
human non small cell lung cancer cell lines - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: In vitro anticancer effect of azithromycin targeting hypoxic lung cancer cells via the inhibition of mitophagy. Article Snippet: Article Title: THP-1 Monocytic Cells Are Polarized to More Antitumorigenic Macrophages by Serial Treatment with Phorbol-12-Myristate-13-Acetate and PD98059 Article Snippet: The Article Title: GLUT1 sensitizes tumor cells to EGFR-TKIs by binding with activated EGFR and regulating its downstream signaling pathways Article Snippet: Human non-small cell lung cancer cell lines (H838, H1299, H1650, H1975) and Article Title: Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer Article Snippet: Article Title: MMP3 overexpression enhances CAR-T cell infiltration and antitumor activity in a CAF-enriched solid tumor model Article Snippet: Human non-small cell lung cancer cell lines, including Article Title: Pharmacologic activation of PHD2 sensitizes non-small cell lung cancer cells to osimertinib. Article Snippet: Multiple Displacement Amplification:Article Title: Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathways. Article Snippet: Cancer has been a leading cause of death over the last few decades in western countries as well as in Taiwan.. However, traditional therapies are limited by the adverse effects of chemotherapy and radiotherapy, and tumor recurrence may occur.. Therefore, it is critical to develop novel therapeutic drugs. |